Treatment of Malignant Neurocardiogenic Syncope with Dual Chamber Cardiac Pacing and Fluoxetine Hydrochloride
- 1 July 1995
- journal article
- case report
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 18 (7) , 1455-1457
- https://doi.org/10.1111/j.1540-8159.1995.tb02610.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescentsJournal of the American College of Cardiology, 1994
- Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapyCurrent Opinion in Cardiology, 1994
- Recent advances in cardiac pacingCurrent Opinion in Cardiology, 1994
- Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or AsystoleNew England Journal of Medicine, 1993
- Usefulness of Fluoxetine Hydrochloride for Prevention of Resistant Upright Tilt Induced SyncopePacing and Clinical Electrophysiology, 1993
- Dual Chamber Pacing Aborts Vasovagal Syncope Induced by Head‐Up 60° TiltPacing and Clinical Electrophysiology, 1991
- Psychologic Stress, Vasodepressor (Vasovagal) Syncope, and Sudden DeathAnnals of Internal Medicine, 1978